Ieq Capital LLC Grows Position in Medpace Holdings, Inc. (NASDAQ:MEDP)

Ieq Capital LLC boosted its stake in Medpace Holdings, Inc. (NASDAQ:MEDP - Free Report) by 1,090.6% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 27,206 shares of the company's stock after buying an additional 24,921 shares during the period. Ieq Capital LLC owned 0.09% of Medpace worth $9,039,000 at the end of the most recent reporting period.

Several other large investors have also bought and sold shares of MEDP. Private Advisor Group LLC boosted its stake in Medpace by 53.8% during the fourth quarter. Private Advisor Group LLC now owns 2,227 shares of the company's stock worth $740,000 after acquiring an additional 779 shares in the last quarter. Alberta Investment Management Corp grew its holdings in shares of Medpace by 15.3% during the fourth quarter. Alberta Investment Management Corp now owns 4,447 shares of the company's stock valued at $1,477,000 after buying an additional 589 shares during the last quarter. Kestra Investment Management LLC increased its position in shares of Medpace by 58.3% during the fourth quarter. Kestra Investment Management LLC now owns 1,105 shares of the company's stock valued at $367,000 after acquiring an additional 407 shares in the last quarter. Venturi Wealth Management LLC raised its holdings in Medpace by 602.0% in the 4th quarter. Venturi Wealth Management LLC now owns 344 shares of the company's stock worth $114,000 after acquiring an additional 295 shares during the last quarter. Finally, Truist Financial Corp lifted its position in Medpace by 166.2% in the 4th quarter. Truist Financial Corp now owns 10,277 shares of the company's stock valued at $3,414,000 after acquiring an additional 6,417 shares in the last quarter. 77.98% of the stock is owned by institutional investors.

Remove Ads

Medpace Price Performance

Shares of MEDP traded up $4.35 during trading hours on Monday, hitting $344.57. The stock had a trading volume of 155,489 shares, compared to its average volume of 273,583. The firm has a market capitalization of $10.50 billion, a PE ratio of 27.25, a PEG ratio of 3.81 and a beta of 1.36. Medpace Holdings, Inc. has a 12 month low of $302.01 and a 12 month high of $459.77. The stock has a fifty day moving average price of $343.13 and a 200 day moving average price of $346.83.

Medpace (NASDAQ:MEDP - Get Free Report) last released its quarterly earnings results on Monday, February 10th. The company reported $3.67 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $2.96 by $0.71. Medpace had a return on equity of 51.48% and a net margin of 19.17%. As a group, analysts anticipate that Medpace Holdings, Inc. will post 12.29 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

Separately, Robert W. Baird boosted their price target on Medpace from $354.00 to $362.00 and gave the stock a "neutral" rating in a research note on Monday, January 27th. Seven analysts have rated the stock with a hold rating and five have issued a buy rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of "Hold" and an average price target of $381.44.

Medpace Company Profile

Medpace Holdings, Inc engages in the provision of outsourced clinical development services to the biotechnology, pharmaceutical and medical device industries. Its services include medical department, clinical trial management, data-driven feasibility, study-start-up, clinical monitoring, regulatory affairs, patient recruitment and retention, medical writing, biometrics and data sciences, pharmacovigilance, core laboratory, laboratories, clinics, and quality assurance.